Диссертация (1174225), страница 53
Текст из файла (страница 53)
et al. Follicular Fluid redox involvement forovarian follicle growth. // J. Ovarian Res. – 2017. – Vol. 10, N 1. – P.44.186. Giorgi V.S.I., Broi M.G. Da, Paz C.C.P. et al. N-Acetyl-Cysteine and l-CarnitinePrevent Meiotic Oocyte Damage Induced by Follicular Fluid From Infertile WomenWith Mild Endometriosis. // Reprod. Sci. – 2016. – Vol. 23, N 3. – P.342-51.187.
Glavind M.№, Forman A., Arendt L.H. et al. Endometriosis and pregnancycomplications: a Danish cohort study. // Fertil. Steril. – 2017. – Vol. 107, N 1. – P.160166.188. González-Comadran M., Schwarze J.E., Zegers-Hochschild F. et al. The impact ofendometriosis on the outcome of Assisted Reproductive Technology // Reprod. Biol.288Endocrinol. – 2017.
– Vol. 15, N 1. – P.8.189. Goutziomitrou E., Venetis C.A., Kolibianakis E.M. et al. Propofol versusthiopental sodium as anaesthetic agents for oocyte retrieval: a randomized controlledtrial. // Reprod. Biomed. Online. – 2015. – Vol. 31, N 6. – P.752-9.190. Guardo F. Di, Shah M., Cerana M.C. et al. Management of women affected byendometriosis: Are we stepping forward? // J. Endometr. Pelvic Pain Disord. – 2019. –Vol. 11, N 2. – P.77-84.191. Guideline N. Endometriosis: diagnosis and management / Guideline, N.
– 2017. –363 p.192. Hagen C.P., Vestergaard S., Juul A. et al. Low concentration of circulatingantimüllerian hormone is not predictive of reduced fecundability in young healthywomen: a prospective cohort study // Fertil. Steril. – 2012. – Vol. 98, N 6.
– P.16021608.e2.193. Hamdan M., Omar S.Z., Dunselman G., Cheong Y. Influence of endometriosis onassisted reproductive technology outcomes: a systematic review and meta-analysis. //Obste№ Gynecol. – 2015. – Vol. 125, N 1. – P.79-88.194. Hamdan M., Dunselman G., Li №C., Cheong Y.
The impact of endometrioma onIVF/ICSI outcomes: a systematic review and meta-analysis // Hum. Reprod. Update. –2015. – Vol. 21, N 6. – P.809-825.195. Hamdan M., Jones K.№, Cheong Y., Lane S.I.R. The sensitivity of the DNAdamage checkpoint prevents oocyte maturation in endometriosis. // Sci. Rep. – 2016. –Vol. 6. – P.36994.196. Hamilton J.A., Larson A.J., Lower A.M. et al. Routine use of salinehysterosonography in 500 consecutive, unselected, infertile women.
// Hum. Reprod. –1998. – Vol. 13, N 9. – P.2463-73.197. Harb H.M., Gallos I.D., Chu J. et al. The effect of endometriosis on in vitrofertilisation outcome: a systematic review and meta-analysis. // BJOG. – 2013. – Vol.120, N 11. – P.1308-20.198. Harvey A., Kind K., Thompson J. REDOX regulation of early embryodevelopment // Reproduction. – 2002. – P.479-486.289199.
Healy D.L., Breheny S., Halliday J. et al. Prevalence and risk factors for obstetrichaemorrhage in 6730 singleton births after assisted reproductive technology in VictoriaAustralia. // Hum. Reprod. – 2010. – Vol. 25, N 1. – P.265-74.200. Hirsch M., Duffy J.M.N., Deguara C.S.
et al. Diagnostic accuracy of CancerAntigen 125 (CA125) for endometriosis in symptomatic women: A multi-center study.// Eur. J. Obste№ Gynecol. Reprod. Biol. – 2017. – Vol. 210. – P.102-107.201. Hoenderboom B.M., Benthem B.H.B. Van, Bergen J.E.A.M. Van et al. Relationbetween Chlamydia trachomatis infection and pelvic inflammatory disease, ectopicpregnancy and tubal factor infertility in a Dutch cohort of women previously tested forchlamydia in a chlamydia screening trial // Sex. Transm. Infec№ – 2019. – Vol. 95, N 4.– P.300-306.202.
Hosseini E. Controlled Ovarian Stimulation in Endometriosis Patients Can BeIndividualized by Anti-Mullerian Hormone Levels // Acta Endocrinol. – 2017. – Vol.13, N 2. – P.195-202.203. Huang B., Li Z., Ai J. et al. Antioxidant capacity of follicular fluid from patientsundergoing in vitro fertilization. // In№ J. Clin. Exp. Pathol. – 2014. – Vol. 7, N 5. –P.2273-82.204.
Hughesdon P.E. The structure of endometrial cysts of the ovary. // J. Obste№Gynaecol. Br. Emp. – 1957. – Vol. 64, N 4. – P.481-7.205. Ignatov №, Eggemann H., Dan Costa S., Ignatov A. Endometrial cancer afterulipristal acetate for uterine fibroma // Eur. J. Obste№ Gynecol. Reprod. Biol. – 2017. –Vol. 219. – P.134.206. Ikechebelu J.I., Eleje G.U., Joe-Ikechebelu N.N.
et al. Comparison of theprevalence of adhesions at the time of diagnostic laparoscopy for infertility betweenpatient who had open myomectomy and those who had no previous pelvic-abdominalsurgery or pelvic inflammatory disease. // Niger. J. Clin. Prac№ – 2018. – Vol. 21,N 11. – P.1415-1421.207. Ito F., Yamada Y., Shigemitsu A.
et al. Role of Oxidative Stress in EpigeneticModification in Endometriosis. // Reprod. Sci. – 2017. – Vol. 24, N 11. – P.1493-1502.208. Iwabuchi №, Yoshimoto C., Shigetomi H., Kobayashi H. Cyst fluid hemoglobin290species in endometriosis and its malignant transformation: The role of metallobiology. //Oncol. Let№ – 2016.
– Vol. 11, N 5. – P.3384-3388.209. Iwabuchi №, Yoshimoto C., Shigetomi H., Kobayashi H. Oxidative Stress andAntioxidant Defense in Endometriosis and Its Malignant Transformation // Oxid. Med.Cell. Longev. – 2015. – Vol. 2015. – P.1-7.210. Jacobson №Z., Duffy J.M.N., Barlow D.H. et al. WITHDRAWN: Laparoscopicsurgery for subfertility associated with endometriosis. // Cochrane database Sys№ Rev.– 2014.
– №8. – P.CD001398.211. Jana S.K., Babu N., Chattopadhyay R. et al. Upper control limit of reactive oxygenspecies in follicular fluid beyond which viable embryo formation is not favorable. //Reprod. Toxicol. – 2010. – Vol. 29, N 4. – P.447-51.212. Jensen J.№, Schlaff W., Gordon K. Use of combined hormonal contraceptives forthe treatment of endometriosis-related pain: a systematic review of the evidence //Fertil. Steril.
– 2018. – Vol. 110, N 1. – P.137-152.e1.213. Jiang J., Jiang Z., Xue M. Serum and peritoneal fluid levels of interleukin-6 andinterleukin-37 as biomarkers for endometriosis. // Gynecol. Endocrinol. – 2019. – Vol.35, N 7. – P.571-575.214. Johnson N.P.N.P., Hummelshoj L., Abrao M.S. et al. Consensus on currentmanagement of endometriosis // Hum. Reprod. – 2013. – Vol. 28, N 6. – P.1552-1568.215. Kala M., Shaikh M.V., Nivsarkar M. Equilibrium between anti-oxidants andreactive oxygen species: a requisite for oocyte development and maturation. // Reprod.Med. Biol. – 2017. – Vol.
16, N 1. – P.28-35.216. Keane K., Cruzat V.F., Wagle S. et al. Specific ranges of anti-Mullerian hormoneand antral follicle count correlate to provide a prognostic indicator for IVF outcome. //Reprod. Biol. – 2017. – Vol. 17, N 1. – P.51-59.217. Kersten F.A.M., Hermens R.P.G.M., Braat D.D.M. et al. Overtreatment in coupleswith unexplained infertility. // Hum.
Reprod. – 2015. – Vol. 30, N 1. – P.71-80.218. Khazaei M., Aghaz F. Reactive Oxygen Species Generation and Use ofAntioxidants during In Vitro Maturation of Oocytes. // In№ J. Fertil. Steril. – Vol. 11,N 2. – P.63-70.291219. Kho R.M., Andres M.P., Borrelli G.M. et al. Surgical treatment of different typesof endometriosis: Comparison of major society guidelines and preferred clinicalalgorithms // Best Prac№ Res. Clin. Obste№ Gynaecol. – 2018. – Vol. 51. – P.102-110.220. Kobayashi Y., Osanai K., Tanaka K. et al. Endometriotic cyst fluid inducesreactive oxygen species (ROS) in human immortalized epithelial cells derived fromovarian endometrioma // Redox Rep.
– 2017. – Vol. 22, N 6. – P.361-366.221. Koninckx P.R., Ussia A., Adamyan L. et al. Pathogenesis of endometriosis: thegenetic/epigenetic theory // Fertil. Steril. – 2019. – Vol. 111, N 2. – P.327-340.222. Koo H.S., Park C.W., Cha S.H., Yang K.M. Serial Evaluation of EndometrialBlood Flow for Prediction of Pregnancy Outcomes in Patients Who UnderwentControlled Ovarian Hyperstimulation and In Vitro Fertilization and Embryo Transfer //J. Ultrasound Med.
– 2018. – Vol. 37, N 4. – P.851-857.223. Koo Y.-J., Kim №-J., Lee J.-E. et al. Risk of torsion and malignancy by adnexalmass size in pregnant women. // Acta Obste№ Gynecol. Scand. – 2011. – Vol. 90, N 4.– P.358-61.224. Kurdoglu Z., Gursoy R., Kurdoglu M. et al. Comparison of the clinical value ofCA 19-9 versus CA 125 for the diagnosis of endometriosis.
// Fertil. Steril. – 2009. –Vol. 92, N 5. – P.1761-3.225. Laganà A.S., Vitale S.G., Granese R. et al. Clinical dynamics of Dienogest for thetreatment of endometriosis: from bench to bedside // Expert Opin. Drug Metab. Toxicol.– 2017.226. Laganà A.S., Salmeri F.M., Vitale S.G. et al. Stem Cell Trafficking DuringEndometriosis: May Epigenetics Play a Pivotal Role? // Reprod. Sci. – 2018. – Vol.
25,N 7. – P.978-979.227. Lalani S., Choudhry A.J., Firth B. et al. Endometriosis and adverse maternal, fetaland neonatal outcomes, a systematic review and meta-analysis. // Hum. Reprod. – 2018.– Vol. 33, N 10. – P.1854-1865.228. Lalani S., Choudhry A.J., Firth B. et al. Endometriosis and adverse maternal, fetaland neonatal outcomes, a systematic review and meta-analysis. // Hum.
Reprod. – 2018.– Vol. 33, N 10. – P.1854-1865.292229.Laschke M.W.,Menger M.D.Basicmechanismsofvascularizationinendometriosis and their clinical implications. // Hum. Reprod. Update. – 2018. – Vol.24, N 2. – P.207-224.230. Lee H., Elahi F., Lee J. et al. Supplement of cilostamide in growth mediumimproves oocyte maturation and developmental competence of embryos derived fromsmall antral follicles in pigs. // Theriogenology. – 2017. – Vol. 91. – P.1-8.231. Lee J.H., Song J.Y., Yi K.W.
et al. Effectiveness of Dienogest for Treatment ofRecurrent Endometriosis: Multicenter Data // Reprod. Sci. – 2018. – Vol. 25, N 10. –P.1515-1522.232. Lee Y., Lee Y., Lee S. et al. Correlation of Preoperative Biomarkers with Severityof Adhesion in Endometriosis. // J. Gynecol. Obste№ Hum. Reprod. – 2019.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
